Literature DB >> 2578964

Monoclonal antibodies specific for murine IgM. II. Activation of B lymphocytes by monoclonal antibodies specific for the four constant domains of IgM.

M Leptin.   

Abstract

Seventeen monoclonal antibodies specific for IgM and one kappa light chain-specific antibody were used to test the effect of immunoglobulin (Ig)-specific antibodies on B cell activation. In soluble form, either alone or together with T cell-derived growth and maturation factors, none of the antibodies stimulated resting B cells to divide or secrete Ig. The soluble antibodies inhibited lipopolysaccharide-induced B cell activation. The inhibitory effect of the antibodies was independent of their Fc part. When immobilized, the same antibodies could activate B cells to proliferate and together with T cell-derived maturation factors to mature to plasma cells. Occupation by immobilized antibody of determinants on any of the four constant region domains and on the light chain of surface Ig can lead to the stimulation of B cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578964     DOI: 10.1002/eji.1830150206

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  One synchronous wave of B cell development in mouse fetal liver changes at day 16 of gestation from dependence to independence of a stromal cell environment.

Authors:  A Strasser; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

2.  Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.

Authors:  S M Rudich; K H Roux; R J Winchester; P K Mongini
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

3.  Monoclonal antibodies reactive with the mouse interleukin 5 receptor.

Authors:  A G Rolink; F Melchers; R Palacios
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

4.  Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo.

Authors:  A Rolink; A Kudo; H Karasuyama; Y Kikuchi; F Melchers
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

5.  Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.

Authors:  H Karasuyama; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

6.  A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.

Authors:  H Karasuyama; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

7.  Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.

Authors:  L Reininger; T Radaszkiewicz; M Kosco; F Melchers; A G Rolink
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

8.  Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies.

Authors:  S M Rudich; R Winchester; P K Mongini
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

Review 9.  B lymphocyte antigen receptor signaling: initiation, amplification, and regulation.

Authors:  Thomas A Packard; John C Cambier
Journal:  F1000Prime Rep       Date:  2013-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.